|
|
|
|
|
by alevskaya
1662 days ago
|
|
You're really into stacking these hypotheticals. Why would anyone bother developing a pile of fiddly new vectors? cui bono? Vector development sucks, I've done it in simpler virus families. And why do it completely markerless? Remember that the other odd thing about this grant was that a lot of the genetic work was supposed to be done in the US. If it were already being done we'd probably have had those sequences in -our- databases! |
|
It's highly unlikely that an established group would write a proposal that didn't describe their current research trajectory.
Although you have made a lot of arguments against it, I still don't know why it seems so unreasonable to you that SARS-CoV-2 might have laboratory origins. I think it's just that your prior expectations run against this. To me it's much easier to imagine than a natural spillover, given the modern urban circumstances and very unusual viral features and phenotype. Maybe my work experience is more aligned with this possibility than yours?